V580E

Category 4 — Stable Fold, Function DisruptedUncertain significanceTransmembrane · predictedSource card

Valine → Glutamic acid at position 580 · Transmembrane helix 9 · WFS1 (Wolframin)

Interactive 3D Structure

Wild-type reference

Wild-type V580 — hydrogen bond to G576

Fullscreen ↗

DynaMut2 mutant · V580E

Mutant E580 — hydrogen bond to G576 lost (2 contacts lost)

Fullscreen ↗

Bond changes · DynaMut2 interaction analysis

2 lost4 gained6 preserved

Interaction type	Wild-type partner	Mutant partner	Status
Hydrogen bond	G576	G576	Preserved
Hydrogen bond	—	L577	Gained
Hydrogen bond	Q584	Q584	Preserved
Polar contact	G576	G576	Preserved
Polar contact	—	L577	Gained
Polar contact	L583	L583	Preserved
Polar contact	Q584	Q584	Preserved
Van der Waals	G576	—	Lost
Van der Waals	—	L577	Gained
Van der Waals	Q584	Q584	Preserved
Hydrophobic	—	L577	Gained
Hydrophobic	Q584	—	Lost

Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.

Computational Predictions

DynaMut2 ΔΔG

0.33kcal/mol

Stabilising — mild

AlphaMissense

0.389

ambiguous

AlphaFold pLDDT

model confidence

Schema

Cat 4

Category 4 — Stable Fold, Function Disrupted

Clinical Evidence

ClinVar classificationUncertain significance/Uncertain risk allele

Review statuscriteria provided, multiple submitters, no conflicts

Associated conditionsInborn genetic diseases; Wolfram syndrome 1; Autosomal dominant nonsyndromic hearing loss 6; WFS1-Related Spectrum Disorders; Cataract 41; Type 2 diabetes mellitus; Wolfram-like syndrome

Population frequency (gnomAD v4)Ultra-rare · AF 0.0076%

cDNA changec.1739T>A

ClinVar accessionVCV000904987

Last evaluated2025/10/21 00:00

Observed at very low frequency in gnomAD.

Full Variant Card

WFS1 Wolframin — V580E Variant Card

Molecular Atlas Pilot · RareResearch.AI · Generated by wolfram-variant-card skill

Valine → Glutamic acid at position 580. Transmembrane helix 9. ClinVar Uncertain significance/Uncertain risk allele, AlphaMissense 0.389, DynaMut2 ΔΔG +0.33 kcal/mol (stabilising).

Identity

Field	Value
Variant	V580E (p.Valine580Glutamic acid)
DNA change	c.1739T>A
Gene · Protein	WFS1 · Wolframin (890 aa)
UniProt	O76024 · WFS1_HUMAN
ClinVar accession	VCV000904987
Amino acid change	Valine (V) → Glutamic acid (E)

Structural Context

Field	Value
AlphaFold model	AF-O76024-F1, v6
pLDDT at residue 580	86.75 — well-folded
Domain	Transmembrane helix 9
Position context	Inside Transmembrane helix 9 · position 580 is bilayer-embedded
IDR flag	No — pLDDT above 50 threshold

UniProt features at this position:

(none catalogued)

Position 580 sits in a transmembrane helix (Transmembrane helix 9). Wolframin has eleven such helices anchoring it in the ER membrane; substitutions inside the bilayer-embedded segments can disrupt helix packing, lipid contacts, and the overall ER topology of the protein. The wild-type residue is small hydrophobic (valine — branched); the mutant is negatively charged (glutamate — carboxylate). The chemistry shift implies altered local packing, hydrogen-bonding, and/or electrostatics at this site.

Computational Predictions

AlphaMissense

Field	Value
am_pathogenicity	0.3885
am_class	ambiguous
Interpretation	Likely benign (threshold 0.564)

DynaMut2

Field	Value
ΔΔG (kcal/mol)	0.33 (Stabilising)
Job ID	178094701698
Result URL	https://biosig.lab.uq.edu.au/dynamut2/results_prediction/178094701698

Clinical Evidence

Field	Value
Classification	Uncertain significance/Uncertain risk allele
Review status	criteria provided, multiple submitters, no conflicts
Last evaluated	2025/10/21 00:00
Inheritance	Autosomal dominant pattern indicated by associated DFNA6/14/38 (WFS1 hearing loss 6).
WFS1 variant landscape	V580E is 1 of ~326 pathogenic-spectrum variants in WFS1 (out of 2,243 catalogued in ClinVar)

Inborn genetic diseases
Wolfram syndrome 1
Autosomal dominant nonsyndromic hearing loss 6
WFS1-Related Spectrum Disorders
Cataract 41
Type 2 diabetes mellitus
Wolfram-like syndrome

Research Path Decision Tree

ΔΔG < 2  + binding site affected   →  CATEGORY 3 — docking experiments
ΔΔG 2–4                            →  CATEGORY 2 — pharmacological chaperones
ΔΔG > 4                            →  CATEGORY 1 — gene therapy
pLDDT < 50                         →  CATEGORY 5 — IDR, experimental only
Stable fold + functional site hit  →  CATEGORY 4 — site-specific docking

Final Schema Categorization

Category 4 — Stable Fold, Function Disrupted

<strong>Category 4 — Stable Fold, Function Disrupted</strong><br/><br/>|ΔΔG|=0.33 negligible. Likely site-specific functional disruption — docking strategy.

Why this card matters. Wolframin's fold survives this substitution (|ΔΔG|=0.33 kcal/mol). The pathogenic signal is real — AlphaMissense places it at 0.389. Protein still folds, but a specific local site is broken. Pharmacological chaperones and small-molecule binders are the rational therapeutic vector.

Files in this folder

AF-O76024-F1-model_v6.pdb — AlphaFold structure
V580E_molstar_viewer.html — interactive 3D viewer (auto-highlights position 580 with ball-and-stick + neighbors within 5Å)
V580E_variant_card.md — this card (source of truth)
V580E_variant_card.html — styled printable card
V580E_dynamut2_summary.html — clean offline DynaMut2 result card
dynamut2_result.json — structured result data
dynamut2_result_page.html — local snapshot of the Biosig result page (asset URLs absolutized)
V580E_wildtype_interactions.pse / V580E_mutant_interactions.pse — PyMOL sessions

Generated by wolfram-variant-card skill · RareResearch.AI Molecular Atlas Every assumption documented. Every score sourced.

Therapeutic Strategy Handoff · prediction

Feed this card to Wolfram Intelligence

Download the V580E PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.

Download V580E PDF card ↓Strategies are AI-generated predictions, not validated therapeutics.